Chapter 10 Caveolae and Caveolins in the Vascular System: Functional Roles in Endothelia, Macrophages, and Smooth Muscle Cells

Advances in Molecular and Cell Biology

Volumn 36, Issue , 2005, Pages 187-209

  Hassan, Ghada S ^a   Lisanti, Michael P ^a   Frank, Philippe G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646451029     PISSN: 15692558     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2558(05)36010-3     Document Type: Review

References (110)

1. Anderson R.G.W. The caveolae membrane system. Ann. Rev. Biochem. 67 (1998) 199-225
2. Assmann G., Von Eckardstein A., and Funke H. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease: Insights from mutations. Circulation 87 Suppl. (1993) III28-III34
3. Babitt J., Trigatti B., Rigotti A., Smart E.J., Anderson R.G., Xu S., and Krieger M. Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J. Biol. Chem. 272 (1997) 13242-13249
4. Baorto D.M., Gao Z., Malaviya R., Dustin M.L., van der Merwe A., Lublin D.M., and Abraham S.N. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 389 (1997) 636-639
5. Bendayan M., and Rasio E.A. Transport of insulin and albumin by the microvascular endothelium of the rete mirabile. J. Cell Sci. 109 Pt. 7 (1996) 1857-1864
6. Bernard D.W., Rodriguez A., Rothblat G.H., and Glick J.M. cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J774 macrophages. J. Biol. Chem. 266 (1991) 710-716
7. Bist A., Fielding P.E., and Fielding C.J. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc. Natl. Acad. Sci. USA 94 (1997) 10693-10698
8. Blair A., Shaul P.W., Yuhanna I.S., Conrad P.A., and Smart E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J. Biol. Chem. 274 (1999) 32512-32519
9. Brouet A., Sonveaux P., Dessy C., Moniotte S., Balligand J.L., and Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ. Res. 89 (2001) 866-873
10. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 124 Suppl. (1996) S1-S9
11. Chen J., Braet F., Brodsky S., Weinstein T., Romanov V., Noiri E., and Goligorsky M.S. VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells. Am. J. Physiol. Cell Physiol. 282 (2002) C1053-C1063
12. Dehouck B., Fenart L., Dehouck M.P., Pierce A., Torpier G., and Cecchelli R. A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier. J. Cell Biol. 138 (1997) 877-889
13. Doyle D.D., Upshaw-Earley J., Bell E., and Palfrey H.C. Expression of caveolin-3 in rat aortic vascular smooth muscle cells is determined by developmental state. Biochem. Biophys. Res. Commun. 304 (2003) 22-25
14. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F.C., Schedl A., Haller H., and Kurzchalia T.V. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293 (2001) 2449-2452
15. Dreja K., Voldstedlund M., Vinten J., Tranum-Jensen J., Hellstrand P., and Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1267-1272
16. Everson W.V., and Smart E.J. Influence of caveolin, cholesterol, and lipoproteins on nitric oxide synthase. implications for vascular disease. Trends Cardiovasc. Med. 11 (2001) 246-250
17. Feron O., Dessy C., Moniotte S., Desager J.P., and Balligand J.L. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J. Clin. Invest. 103 (1999) 897-905
18. Fielding P.E., and Fielding C.J. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34 (1995) 14288-14292
19. Fielding P.E., and Fielding C.J. Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae. Biochemistry 35 (1996) 14932-14938
20. Frank P.G., Galbiati F., Volonte D., Razani B., Cohen D.E., Marcel Y.L., and Lisanti M.P. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am. J. Physiol. 280 (2001) 1204-1214
21. Frank P.G., Lee H., Park D.S., Tandon N.N., Scherer P.E., and Lisanti M.P. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 98-105
22. Frank P.G., Marcel Y.L., Connelly M.A., Lublin D.M., Franklin V., Williams D.L., and Lisanti M.P. Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. Biochemistry 41 (2002) 11931-11940
23. Frank P.G., Pedraza A., Cohen D.E., and Lisanti M.P. Adenovirus-mediated expression of caveolin-1 in mouse liver increases plasma high-density lipoprotein levels. Biochemistry 40 (2001) 10892-10900
24. Frank P.G., Woodman S.E., Park D.S., and Lisanti M.P. Caveolin, caveolae, and endothelial cell function. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1161-1168
25. Fry D.L., Herderick E.E., and Johnson D.K. Local intimal-medial uptakes of 125I-albumin, 125I-LDL, and parenteral Evans blue dye protein complex along the aortas of normocholesterolemic minipigs as predictors of subsequent hypercholesterolemic atherogenesis. Arterioscler. Thromb. 13 (1993) 1193-1204
26. Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N. Engl. J. Med. 326 (1992) 310-318
27. Galvez B.G., Matias-Roman S., Yanez-Mo M., Vicente-Manzanares M., Sanchez-Madrid F., and Arroyo A.G. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol. Biol. Cell 15 (2004) 678-687
28. Garcia-Cardena G., Fan R., Stern D., Liu J., and Sessa W.C. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271 (1996) 27237-27240
29. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83 (1989) 1774-1777
30. Gargalovic P., and Dory L. Caveolin-1 and caveolin-2 expression in mouse macrophages. High density lipoprotein 3-stimulated secretion and a lack of significant subcellular co-localization. J. Biol. Chem. 276 (2001) 26164-26170
31. Gargalovic P., and Dory L. Caveolins and macrophage lipid metabolism. J. Lipid Res. 44 (2003) 11-21
32. Gargalovic P., and Dory L. Cellular apoptosis is associated with increased caveolin-1 expression in macrophages. J. Lipid Res. 44 (2003) 1622-1632
33. Ghitescu L., Fixman A., Simonescu M., and Simonescu N. Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: Receptor-mediated transcytosis. J. Cell Biol. 102 (1986) 1304-1311
34. Gordon D.J., and Rifkind B.M. High-density lipoprotein-The clinical implications of recent studies. N. Engl. J. Med. 321 (1989) 1311-1316
35. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62 (1977) 707-714
36. Graf G.A., Connell P.M., Van der Westhuyzen D.R., and Smart E.J. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol ethers into caveolae. J Biol. Chem. 274 (1999) 12043-12048
37. Griendling K.K., Harrison D.G., and Alexander R.W. Molecular and cellular biology of blood vessels. In: Fuster V., Alexander R.W., and R. A. O.R. (Eds). Hurst's The Heart Vol. 1 (2001), McGraw-Hill, New York 127-145
38. Griffoni C., Spisni E., Santi S., Riccio M., Guarnieri T., and Tomasi V. Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 276 (2000) 756-761
39. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353-364
40. Harrison D.G., and Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: Implications for impaired vasomotion. Am. J. Cardiol. 75 (1995) 75B-81B
41. Hassan G.S., Jasmin J.-F., Schubert W., Frank P.G., and Lisanti M.P. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 43 (2004) 8312-8321
42. Huh H.Y., Pearce S.F., Yesner L.M., Schindler J.L., and Silverstein R.L. Regulated expression of CD36 during monocyte-to-macrophage differentiation: Potential role of CD36 in foam cell formation. Blood 87 (1996) 2020-2028
43. Impagnatiello M.A., Weitzer S., Gannon G., Compagni A., Cotten M., and Christofori G. Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J. Cell Biol. 152 (2001) 1087-1098
44. Isshiki M., Ando J., Yamamoto K., Fujita T., Ying Y., and Anderson R.G. Sites of Ca(2+) wave initiation move with caveolae to the trailing edge of migrating cells. J. Cell Sci. 115 (2002) 475-484
45. Isshiki M., Ying Y.S., Fujita T., and Anderson R.G. A molecular sensor detects signal transduction from caveolae in living cells. J. Biol. Chem. 277 (2002) 43389-43398
46. Ju H., Zou R., Venema V.J., and Venema R.C. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272 (1997) 18522-18525
47. Kariya K., Kawahara Y., Araki S., Fukuzaki H., and Takai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 80 (1989) 143-147
48. Kawabe J., Okumura S., Lee M.C., Sadoshima J., and Ishikawa Y. Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H1845-H1852
49. Kawashima S., Yamashita T., Ozaki M., Ohashi Y., Azumi H., Inoue N., Hirata K., Hayashi Y., Itoh H., and Yokoyama M. Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 201-207
50. Kim M.-J., Dawes J., and Jessup W. Transendothelial transport of modified low-density lipoproteins. Atherosclerosis 108 (1994) 5-17
51. Kumar A., and Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2238-2244
52. Labrecque L., Royal I., Surprenant D.S., Patterson C., Gingras D., and Beliveau R. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol. Biol. Cell 14 (2003) 334-347
53. Li Q.Q., Tsujita M., and Yokoyama S. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 36 (1997) 12045-12052
54. Lisanti M.P., Scherer P., Tang Z.-L., and Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: A signalling hypothesis. Trends Cell Biol. 4 (1994) 231-235
55. Lisanti M.P., Scherer P.E., Vidugiriene J., Tang Z., Hermanowski-Vosatka A., Tu Y.H., Cook R.F., and Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J. Cell Biol. 126 (1994) 111-126
56. Liu J., Wang X.B., Park D.S., and Lisanti M.P. Caveolin-1 expression enhances endothelial capillary tubule formation. J. Biol. Chem. 277 (2002) 10661-10668
57. Lohn M., Furstenau M., Sagach V., Elger M., Schulze W., Luft F.C., Haller H., and Gollasch M. Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ. Res. 87 (2000) 1034-1039
58. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
59. Majno G., and Palade G.E. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: An electron microscopic study. J. Biophys. Biochem. Cytol. 11 (1961) 571-605
60. Matveev S., Uittenbogaard A., van Der Westhuyzen D., and Smart E.J. Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur. J. Biochem. 268 (2001) 5609-5616
61. Matveev S., van der Westhuyzen D.R., and Smart E.J. Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J. Lipid Res. 40 (1999) 1647-1654
62. McGill Jr. H.C., Geer J.C., and Holman R.L. Sites of vascular vulnerability in dogs demonstrated by Evans blue. AMA Arch. Pathol. 64 (1957) 303-311
63. Mendez A.J., Lin G., Wade D.P., Lawn R.M., and Oram J.F. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J. Biol. Chem. 276 (2001) 3158-3166
64. 2+-calmodulin and caveolin. J. Biol. Chem. 272 (1997) 15583-15586
65. Miller N.E., Thelle D.S., Forde O.H., and Mjos O.D. The Tromso heart-study. High-density lipoprotein and coronary heart disease: A prospective case-control study. Lancet 1 (1977) 965-968
66. Minshall R.D., Tiruppathi C., Vogel S.M., and Malik A.B. Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem. Cell Biol. 117 (2002) 105-112
67. Minshall R.D., Tiruppathi C., Vogel S.M., Niles W.D., Gilchrist A., Hamm H.E., and Malik A.B. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J. Cell Biol. 150 (2000) 1057-1070
68. Ogawa K., Imai M., Ogawa T., Tsukamoto Y., and Sasaki F. Caveolar and intercellular channels provide major transport pathways of macromolecules across vascular endothelial cells. Anat. Rec. 264 (2001) 32-42
69. Oh P., McIntosh D.P., and Schnitzer J.E. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J. Cell Biol. 141 (1998) 101-114
70. Packham M.A., Rowsell H.C., Jorgensen L., and Mustard J.F. Localized protein accumulation in the wall of the aorta. Exp. Mol. Pathol. 7 (1967) 214-232
71. Peterson T.E., Guicciardi M.E., Gulati R., Kleppe L.S., Mueske C.S., Mookadam M., Sowa G., Gores G.J., Sessa W.C., and Simari R.D. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1521-1527
72. Peterson T.E., Kleppe L.S., Caplice N.M., Pan S., Mueske C.S., and Simari R.D. The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 265 (1999) 722-727
73. Predescu D., and Palade G.E. Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am. J. Physiol. 265 (1993) H725-H733
74. Predescu S.A., Predescu D.N., and Palade G.E. Endothelial transcytotic machinery involves supramolecular protein-lipid complexes. Mol. Biol. Cell 12 (2001) 1019-1033
75. Razani B., Combs T.P., Wang X.B., Frank P.G., Park D.S., Russell R.G., Li M., Tang B., Jelicks L.A., Scherer P.E., and Lisanti M.P. Caveolin-1 deficient mice are lean, resistant to diet-induced obesity, and show hyper-triglyceridemia with adipocyte abnormalities. J. Biol. Chem. 277 (2001) 8635-8647
76. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., Macaluso F., Russell R.G., Li M., Pestell R.G., Di Vizio D., Hou Jr. H., Kneitz B., Lagaud G., Christ G.J., Edelmann W., and Lisanti M.P. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276 (2001) 38121-38138
77. Razani B., Park D.S., Miyanaga Y., Ghatpande A., Cohen J., Wang X.B., Scherer P.E., Evans T., and Lisanti M.P. Molecular cloning and developmental expression of the caveolin gene family in the amphibian Xenopus laevis. Biochemistry 41 (2002) 7914-7924
78. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362 (1993) 801-809
79. Ross R. Atherosclerosis is an inflammatory disease. Am. Heart J. 138 (1999) S419-S420
80. Schnitzer J.E., Allard J., and Oh P. NEM inhibits transcytosis, endocytosis, and capillary permeability: Implication of caveolae fusion in endothelia. Am. J. Physiol. 268 (1995) H48-H55
81. Schnitzer J.E., Liu J., and Oh P. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J. Biol. Chem. 270 (1995) 14399-14404
82. Schnitzer J.E., Oh P., Pinney E., and Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: Reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127 (1994) 1217-1232
83. Schubert W., Frank P.G., Razani B., Park D.S., Chow C.W., and Lisanti M.P. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J. Biol. Chem. 276 (2001) 48619-48622
84. Schubert W., Frank P.G., Woodman S.E., Hyogo H., Cohen D.E., Chow C.W., and Lisanti M.P. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J. Biol. Chem. 277 (2002) 40091-40098
85. Shaul P.W. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J. Physiol. 547 (2003) 21-33
86. Shaul P.W., Smart E.J., Robinson L.J., German Z., Yuhanna I.S., Ying Y.S., Anderson R.G.W., and Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271 (1996) 6518-6522
87. Simionescu M., Gafencu A., and Antohe F. Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc. Res. Tech. 57 (2002) 269-288
88. Smart E.J., Graf G.A., McNiven M.A., Sessa W.C., Engelmen J.A., Scherer P.E., Okamoto T., and Lisanti M.P. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19 (1999) 7289-7304
89. Smart E.J., Ying Y.-s., Donzell W.C., and Anderson R.G.W. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271 (1996) 29427-29435
90. Somer J.B., and Schwartz C.J. Focal 3 H-cholesterol uptake in the pig aorta. Atherosclerosis 13 (1971) 293-304
91. Somlyo A. Ultrastructure of the microvascular wall: Functional correlations. Handbook of Physiology, the Cardiovascular System, Vascular Smooth Muscle Vol. II (1980), American Physiological Society, Bethesda, MD. Oxford University Press 33-67
92. Spisni E., Griffoni C., Santi S., Riccio M., Marulli R., Bartolini G., Toni M., Ullrich V., and Tomasi V. Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. Exp. Cell Res. 266 (2001) 31-43
93. Stahl A., and Mueller B.M. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J. Cell Biol. 129 (1995) 335-344
94. Takahashi M., Ikeda U., Masuyama J., Funayama H., Kano S., and Shimada K. Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 8 (1996) 817-821
95. Thyberg J. Caveolin-1 and caveolae act as regulators of mitogenic signaling in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1481-1483
96. Thyberg J., Roy J., Tran P.K., Blomgren K., Dumitrescu A., and Hedin U. Expression of caveolae on the surface of rat arterial smooth muscle cells is dependent on the phenotypic state of the cells. Lab. Invest. 77 (1997) 93-101
97. Tiruppathi C., Song W., Bergenfeldt M., Sass P., and Malik A.B. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J. Biol. Chem. 272 (1997) 25968-25975
98. Uittenbogaard A., Shaul P.W., Yuhanna I.S., Blair A., and Smart E.J. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J. Biol. Chem. 275 (2000) 11278-11283
99. van Deurs B., Roepstorff K., Hommelgaard A.M., and Sandvig K. Caveolae: Anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol. 13 (2003) 92-100
100. Vane J.R., Anggard E.E., and Botting R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323 (1990) 27-36
101. Vasile E., Qu H., Dvorak H.F., and Dvorak A.M. Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels. J. Histochem. Cytochem. 47 (1999) 159-167
102. Vasile E., Simionescu M., and Simionescu N. Visualization of the binding, endocytosis, and transcytosis of low density lipoprotein in the arterial endothelium in situ. J. Cell Biol. 96 (1983) 1677-1689
103. Wang L., Connelly M.A., Ostermeyer A.G., Chen H.H., Williams D.L., and Brown D.A. Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines. J. Lipid Res. 44 (2003) 807-815
104. Wickstrom S.A., Alitalo K., and Keski-Oja J. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res. 62 (2002) 5580-5589
105. Wickstrom S.A., Alitalo K., and Keski-Oja J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J. Biol. Chem. 278 (2003) 37895-37901
106. Wilson P.W., Anderson K.M., Harris T., Kannel W.B., and Castelli W.P. Determinants of change in total cholesterol and HDL-C with age: The Framingham Study. J. Gerontol. 49 (1994) M252-M257
107. Woodman S.E., Ashton A.W., Schubert W., Lee H., Williams T.M., Medina F.A., Wyckoff J.B., Combs T.P., and Lisanti M.P. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. Am. J. Pathol. 162 (2003) 2059-2068
108. Woodman S.E., Cheung M.W., Tarr M., North A.C., Schubert W., Lagaud G., Marks C.B., Russell R.G., Hassan G.S., Factor S.M., Christ G.J., and Lisanti M.P. Urogenital alterations in aged male caveolin-1 knockout mice. J. Urol. 171 (2004) 950-957
109. Zeidan A., Broman J., Hellstrand P., and Sward K. Cholesterol dependence of vascular ERK1/2 activation and growth in response to stretch: Role of endothelin-1. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1528-1534
110. Zhu Y., Liao H.L., Wang N., Yuan Y., Ma K.S., Verna L., and Stemerman M.B. Lipoprotein promotes caveolin-1 and Ras translocation to caveolae: Role of cholesterol in endothelial signaling. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2465-2470